Purpura Therapy Drugs Industry Research Report 2025
Description
Summary
According to APO Research, the global Purpura Therapy Drugs market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Purpura Therapy Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Purpura Therapy Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Purpura Therapy Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Purpura Therapy Drugs include Ablynx NV, Bristol-Myers Squibb Company, Grifols Biologicals Inc, Hoffman-L Roche, Hovione, KM Biologics, Lee's Pharmaceutical Holdings Ltd, Omeros Corp and Pfizer Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Purpura Therapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Purpura Therapy Drugs.
The report will help the Purpura Therapy Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Purpura Therapy Drugs market size, estimations, and forecasts are provided in terms of sales volume (k pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Purpura Therapy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Purpura Therapy Drugs Segment by Company
Ablynx NV Bristol-Myers Squibb Company Grifols Biologicals Inc Hoffman-L Roche Hovione KM Biologics Lee's Pharmaceutical Holdings Ltd Omeros Corp Pfizer Inc Roch Sanofi Winthrop Industrie S.A. Amgen Inc Biogen Inc GlaxoSmithKline Plc Novartis AG TakedaPurpura Therapy Drugs Segment by Type
Allergic Purpura Thrombocytopenic PurpuraPurpura Therapy Drugs Segment by Application
Hospital Use Clinic Use Household OthersPurpura Therapy Drugs Segment by Region
North America United States Canada Mexico Europe Germany France U.K. Italy Russia Spain Netherlands Switzerland Sweden Poland Asia-Pacific China Japan South Korea India Australia Taiwan Southeast Asia South America Brazil Argentina Chile Middle East & Africa Egypt South Africa Israel Türkiye GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Purpura Therapy Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Purpura Therapy Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Purpura Therapy Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Purpura Therapy Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Purpura Therapy Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Purpura Therapy Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Purpura Therapy Drugs market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Purpura Therapy Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Purpura Therapy Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Purpura Therapy Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Purpura Therapy Drugs include Ablynx NV, Bristol-Myers Squibb Company, Grifols Biologicals Inc, Hoffman-L Roche, Hovione, KM Biologics, Lee's Pharmaceutical Holdings Ltd, Omeros Corp and Pfizer Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Purpura Therapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Purpura Therapy Drugs.
The report will help the Purpura Therapy Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Purpura Therapy Drugs market size, estimations, and forecasts are provided in terms of sales volume (k pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Purpura Therapy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Purpura Therapy Drugs Segment by Company
Ablynx NV Bristol-Myers Squibb Company Grifols Biologicals Inc Hoffman-L Roche Hovione KM Biologics Lee's Pharmaceutical Holdings Ltd Omeros Corp Pfizer Inc Roch Sanofi Winthrop Industrie S.A. Amgen Inc Biogen Inc GlaxoSmithKline Plc Novartis AG TakedaPurpura Therapy Drugs Segment by Type
Allergic Purpura Thrombocytopenic PurpuraPurpura Therapy Drugs Segment by Application
Hospital Use Clinic Use Household OthersPurpura Therapy Drugs Segment by Region
North America United States Canada Mexico Europe Germany France U.K. Italy Russia Spain Netherlands Switzerland Sweden Poland Asia-Pacific China Japan South Korea India Australia Taiwan Southeast Asia South America Brazil Argentina Chile Middle East & Africa Egypt South Africa Israel Türkiye GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Purpura Therapy Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Purpura Therapy Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Purpura Therapy Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Purpura Therapy Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Purpura Therapy Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Purpura Therapy Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Table of Contents
133 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Purpura Therapy Drugs Market Size (2020-2031)
- 2.2.2 Global Purpura Therapy Drugs Sales (2020-2031)
- 2.2.3 Global Purpura Therapy Drugs Market Average Price (2020-2031)
- 2.3 Purpura Therapy Drugs by Type
- 2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- 2.3.2 Allergic Purpura
- 2.3.3 Thrombocytopenic Purpura
- 2.4 Purpura Therapy Drugs by Application
- 2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.4.2 Hospital Use
- 2.4.3 Clinic Use
- 2.4.4 Household
- 2.4.5 Others
- 3 Market Competitive Landscape by Manufacturers
- 3.1 Global Purpura Therapy Drugs Market Competitive Situation by Manufacturers (2020 Versus 2024)
- 3.2 Global Purpura Therapy Drugs Sales (k pcs) of Manufacturers (2020-2025)
- 3.3 Global Purpura Therapy Drugs Revenue of Manufacturers (2020-2025)
- 3.4 Global Purpura Therapy Drugs Average Price by Manufacturers (2020-2025)
- 3.5 Global Purpura Therapy Drugs Industry Ranking, 2023 VS 2024 VS 2025
- 3.6 Global Manufacturers of Purpura Therapy Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Purpura Therapy Drugs, Product Type & Application
- 3.8 Global Manufacturers of Purpura Therapy Drugs, Established Date
- 3.9 Global Purpura Therapy Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
- 4 Manufacturers Profiled
- 4.1 Ablynx NV
- 4.1.1 Ablynx NV Company Information
- 4.1.2 Ablynx NV Business Overview
- 4.1.3 Ablynx NV Purpura Therapy Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.1.4 Ablynx NV Purpura Therapy Drugs Product Portfolio
- 4.1.5 Ablynx NV Recent Developments
- 4.2 Bristol-Myers Squibb Company
- 4.2.1 Bristol-Myers Squibb Company Company Information
- 4.2.2 Bristol-Myers Squibb Company Business Overview
- 4.2.3 Bristol-Myers Squibb Company Purpura Therapy Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.2.4 Bristol-Myers Squibb Company Purpura Therapy Drugs Product Portfolio
- 4.2.5 Bristol-Myers Squibb Company Recent Developments
- 4.3 Grifols Biologicals Inc
- 4.3.1 Grifols Biologicals Inc Company Information
- 4.3.2 Grifols Biologicals Inc Business Overview
- 4.3.3 Grifols Biologicals Inc Purpura Therapy Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.3.4 Grifols Biologicals Inc Purpura Therapy Drugs Product Portfolio
- 4.3.5 Grifols Biologicals Inc Recent Developments
- 4.4 Hoffman-L Roche
- 4.4.1 Hoffman-L Roche Company Information
- 4.4.2 Hoffman-L Roche Business Overview
- 4.4.3 Hoffman-L Roche Purpura Therapy Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.4.4 Hoffman-L Roche Purpura Therapy Drugs Product Portfolio
- 4.4.5 Hoffman-L Roche Recent Developments
- 4.5 Hovione
- 4.5.1 Hovione Company Information
- 4.5.2 Hovione Business Overview
- 4.5.3 Hovione Purpura Therapy Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.5.4 Hovione Purpura Therapy Drugs Product Portfolio
- 4.5.5 Hovione Recent Developments
- 4.6 KM Biologics
- 4.6.1 KM Biologics Company Information
- 4.6.2 KM Biologics Business Overview
- 4.6.3 KM Biologics Purpura Therapy Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.6.4 KM Biologics Purpura Therapy Drugs Product Portfolio
- 4.6.5 KM Biologics Recent Developments
- 4.7 Lee's Pharmaceutical Holdings Ltd
- 4.7.1 Lee's Pharmaceutical Holdings Ltd Company Information
- 4.7.2 Lee's Pharmaceutical Holdings Ltd Business Overview
- 4.7.3 Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.7.4 Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Product Portfolio
- 4.7.5 Lee's Pharmaceutical Holdings Ltd Recent Developments
- 4.8 Omeros Corp
- 4.8.1 Omeros Corp Company Information
- 4.8.2 Omeros Corp Business Overview
- 4.8.3 Omeros Corp Purpura Therapy Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.8.4 Omeros Corp Purpura Therapy Drugs Product Portfolio
- 4.8.5 Omeros Corp Recent Developments
- 4.9 Pfizer Inc
- 4.9.1 Pfizer Inc Company Information
- 4.9.2 Pfizer Inc Business Overview
- 4.9.3 Pfizer Inc Purpura Therapy Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.9.4 Pfizer Inc Purpura Therapy Drugs Product Portfolio
- 4.9.5 Pfizer Inc Recent Developments
- 4.10 Roch
- 4.10.1 Roch Company Information
- 4.10.2 Roch Business Overview
- 4.10.3 Roch Purpura Therapy Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.10.4 Roch Purpura Therapy Drugs Product Portfolio
- 4.10.5 Roch Recent Developments
- 4.11 Sanofi Winthrop Industrie S.A.
- 4.11.1 Sanofi Winthrop Industrie S.A. Company Information
- 4.11.2 Sanofi Winthrop Industrie S.A. Business Overview
- 4.11.3 Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.11.4 Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Product Portfolio
- 4.11.5 Sanofi Winthrop Industrie S.A. Recent Developments
- 4.12 Amgen Inc
- 4.12.1 Amgen Inc Company Information
- 4.12.2 Amgen Inc Business Overview
- 4.12.3 Amgen Inc Purpura Therapy Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.12.4 Amgen Inc Purpura Therapy Drugs Product Portfolio
- 4.12.5 Amgen Inc Recent Developments
- 4.13 Biogen Inc
- 4.13.1 Biogen Inc Company Information
- 4.13.2 Biogen Inc Business Overview
- 4.13.3 Biogen Inc Purpura Therapy Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.13.4 Biogen Inc Purpura Therapy Drugs Product Portfolio
- 4.13.5 Biogen Inc Recent Developments
- 4.14 GlaxoSmithKline Plc
- 4.14.1 GlaxoSmithKline Plc Company Information
- 4.14.2 GlaxoSmithKline Plc Business Overview
- 4.14.3 GlaxoSmithKline Plc Purpura Therapy Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.14.4 GlaxoSmithKline Plc Purpura Therapy Drugs Product Portfolio
- 4.14.5 GlaxoSmithKline Plc Recent Developments
- 4.15 Novartis AG
- 4.15.1 Novartis AG Company Information
- 4.15.2 Novartis AG Business Overview
- 4.15.3 Novartis AG Purpura Therapy Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.15.4 Novartis AG Purpura Therapy Drugs Product Portfolio
- 4.15.5 Novartis AG Recent Developments
- 4.16 Takeda
- 4.16.1 Takeda Company Information
- 4.16.2 Takeda Business Overview
- 4.16.3 Takeda Purpura Therapy Drugs Sales, Revenue and Gross Margin (2020-2025)
- 4.16.4 Takeda Purpura Therapy Drugs Product Portfolio
- 4.16.5 Takeda Recent Developments
- 5 Global Purpura Therapy Drugs Market Scenario by Region
- 5.1 Global Purpura Therapy Drugs Market Size by Region: 2020 VS 2024 VS 2031
- 5.2 Global Purpura Therapy Drugs Sales by Region: 2020-2031
- 5.2.1 Global Purpura Therapy Drugs Sales by Region: 2020-2025
- 5.2.2 Global Purpura Therapy Drugs Sales by Region: 2026-2031
- 5.3 Global Purpura Therapy Drugs Revenue by Region: 2020-2031
- 5.3.1 Global Purpura Therapy Drugs Revenue by Region: 2020-2025
- 5.3.2 Global Purpura Therapy Drugs Revenue by Region: 2026-2031
- 5.4 North America Purpura Therapy Drugs Market Facts & Figures by Country
- 5.4.1 North America Purpura Therapy Drugs Market Size by Country: 2020 VS 2024 VS 2031
- 5.4.2 North America Purpura Therapy Drugs Sales by Country (2020-2031)
- 5.4.3 North America Purpura Therapy Drugs Revenue by Country (2020-2031)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Purpura Therapy Drugs Market Facts & Figures by Country
- 5.5.1 Europe Purpura Therapy Drugs Market Size by Country: 2020 VS 2024 VS 2031
- 5.5.2 Europe Purpura Therapy Drugs Sales by Country (2020-2031)
- 5.5.3 Europe Purpura Therapy Drugs Revenue by Country (2020-2031)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Purpura Therapy Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Purpura Therapy Drugs Market Size by Country: 2020 VS 2024 VS 2031
- 5.6.2 Asia Pacific Purpura Therapy Drugs Sales by Country (2020-2031)
- 5.6.3 Asia Pacific Purpura Therapy Drugs Revenue by Country (2020-2031)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Purpura Therapy Drugs Market Facts & Figures by Country
- 5.7.1 South America Purpura Therapy Drugs Market Size by Country: 2020 VS 2024 VS 2031
- 5.7.2 South America Purpura Therapy Drugs Sales by Country (2020-2031)
- 5.7.3 South America Purpura Therapy Drugs Revenue by Country (2020-2031)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Purpura Therapy Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Purpura Therapy Drugs Market Size by Country: 2020 VS 2024 VS 2031
- 5.8.2 Middle East and Africa Purpura Therapy Drugs Sales by Country (2020-2031)
- 5.8.3 Middle East and Africa Purpura Therapy Drugs Revenue by Country (2020-2031)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
- 6 Segment by Type
- 6.1 Global Purpura Therapy Drugs Sales by Type (2020-2031)
- 6.1.1 Global Purpura Therapy Drugs Sales by Type (2020-2031) & (k pcs)
- 6.1.2 Global Purpura Therapy Drugs Sales Market Share by Type (2020-2031)
- 6.2 Global Purpura Therapy Drugs Revenue by Type (2020-2031)
- 6.2.1 Global Purpura Therapy Drugs Sales by Type (2020-2031) & (US$ Million)
- 6.2.2 Global Purpura Therapy Drugs Revenue Market Share by Type (2020-2031)
- 6.3 Global Purpura Therapy Drugs Price by Type (2020-2031)
- 7 Segment by Application
- 7.1 Global Purpura Therapy Drugs Sales by Application (2020-2031)
- 7.1.1 Global Purpura Therapy Drugs Sales by Application (2020-2031) & (k pcs)
- 7.1.2 Global Purpura Therapy Drugs Sales Market Share by Application (2020-2031)
- 7.2 Global Purpura Therapy Drugs Revenue by Application (2020-2031)
- 7.2.1 Global Purpura Therapy Drugs Sales by Application (2020-2031) & (US$ Million)
- 7.2.2 Global Purpura Therapy Drugs Revenue Market Share by Application (2020-2031)
- 7.3 Global Purpura Therapy Drugs Price by Application (2020-2031)
- 8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Purpura Therapy Drugs Value Chain Analysis
- 8.1.1 Purpura Therapy Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Purpura Therapy Drugs Production Mode & Process
- 8.2 Purpura Therapy Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Purpura Therapy Drugs Distributors
- 8.2.3 Purpura Therapy Drugs Customers
- 9 Global Purpura Therapy Drugs Analyzing Market Dynamics
- 9.1 Purpura Therapy Drugs Industry Trends
- 9.2 Purpura Therapy Drugs Industry Drivers
- 9.3 Purpura Therapy Drugs Industry Opportunities and Challenges
- 9.4 Purpura Therapy Drugs Industry Restraints
- 10 Report Conclusion
- 11 Disclaimer
- List of Tables
- Table 1. Secondary Sources
- Table 2. Primary Sources
- Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Table 5. Global Purpura Therapy Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
- Table 6. Global Purpura Therapy Drugs Sales (k pcs) of Manufacturers (2020-2025)
- Table 7. Global Purpura Therapy Drugs Sales Market Share by Manufacturers (2020-2025)
- Table 8. Global Purpura Therapy Drugs Revenue of Manufacturers (2020-2025)
- Table 9. Global Purpura Therapy Drugs Revenue Share by Manufacturers (2020-2025)
- Table 10. Global Market Purpura Therapy Drugs Average Price (US$/pcs) of Manufacturers (2020-2025)
- Table 11. Global Purpura Therapy Drugs Industry Ranking, 2023 VS 2024 VS 2025
- Table 12. Global Manufacturers of Purpura Therapy Drugs, Manufacturing Sites & Headquarters
- Table 13. Global Manufacturers of Purpura Therapy Drugs, Product Type & Application
- Table 14. Global Purpura Therapy Drugs Manufacturers Established Date
- Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 16. Global Purpura Therapy Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
- Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
- Table 18. Ablynx NV Company Information
- Table 19. Ablynx NV Business Overview
- Table 20. Ablynx NV Purpura Therapy Drugs Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
- Table 21. Ablynx NV Purpura Therapy Drugs Product Portfolio
- Table 22. Ablynx NV Recent Developments
- Table 23. Bristol-Myers Squibb Company Company Information
- Table 24. Bristol-Myers Squibb Company Business Overview
- Table 25. Bristol-Myers Squibb Company Purpura Therapy Drugs Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
- Table 26. Bristol-Myers Squibb Company Purpura Therapy Drugs Product Portfolio
- Table 27. Bristol-Myers Squibb Company Recent Developments
- Table 28. Grifols Biologicals Inc Company Information
- Table 29. Grifols Biologicals Inc Business Overview
- Table 30. Grifols Biologicals Inc Purpura Therapy Drugs Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
- Table 31. Grifols Biologicals Inc Purpura Therapy Drugs Product Portfolio
- Table 32. Grifols Biologicals Inc Recent Developments
- Table 33. Hoffman-L Roche Company Information
- Table 34. Hoffman-L Roche Business Overview
- Table 35. Hoffman-L Roche Purpura Therapy Drugs Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
- Table 36. Hoffman-L Roche Purpura Therapy Drugs Product Portfolio
- Table 37. Hoffman-L Roche Recent Developments
- Table 38. Hovione Company Information
- Table 39. Hovione Business Overview
- Table 40. Hovione Purpura Therapy Drugs Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
- Table 41. Hovione Purpura Therapy Drugs Product Portfolio
- Table 42. Hovione Recent Developments
- Table 43. KM Biologics Company Information
- Table 44. KM Biologics Business Overview
- Table 45. KM Biologics Purpura Therapy Drugs Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
- Table 46. KM Biologics Purpura Therapy Drugs Product Portfolio
- Table 47. KM Biologics Recent Developments
- Table 48. Lee's Pharmaceutical Holdings Ltd Company Information
- Table 49. Lee's Pharmaceutical Holdings Ltd Business Overview
- Table 50. Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
- Table 51. Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Product Portfolio
- Table 52. Lee's Pharmaceutical Holdings Ltd Recent Developments
- Table 53. Omeros Corp Company Information
- Table 54. Omeros Corp Business Overview
- Table 55. Omeros Corp Purpura Therapy Drugs Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
- Table 56. Omeros Corp Purpura Therapy Drugs Product Portfolio
- Table 57. Omeros Corp Recent Developments
- Table 58. Pfizer Inc Company Information
- Table 59. Pfizer Inc Business Overview
- Table 60. Pfizer Inc Purpura Therapy Drugs Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
- Table 61. Pfizer Inc Purpura Therapy Drugs Product Portfolio
- Table 62. Pfizer Inc Recent Developments
- Table 63. Roch Company Information
- Table 64. Roch Business Overview
- Table 65. Roch Purpura Therapy Drugs Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
- Table 66. Roch Purpura Therapy Drugs Product Portfolio
- Table 67. Roch Recent Developments
- Table 68. Sanofi Winthrop Industrie S.A. Company Information
- Table 69. Sanofi Winthrop Industrie S.A. Business Overview
- Table 70. Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
- Table 71. Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Product Portfolio
- Table 72. Sanofi Winthrop Industrie S.A. Recent Developments
- Table 73. Amgen Inc Company Information
- Table 74. Amgen Inc Business Overview
- Table 75. Amgen Inc Purpura Therapy Drugs Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
- Table 76. Amgen Inc Purpura Therapy Drugs Product Portfolio
- Table 77. Amgen Inc Recent Developments
- Table 78. Biogen Inc Company Information
- Table 79. Biogen Inc Business Overview
- Table 80. Biogen Inc Purpura Therapy Drugs Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
- Table 81. Biogen Inc Purpura Therapy Drugs Product Portfolio
- Table 82. Biogen Inc Recent Developments
- Table 83. GlaxoSmithKline Plc Company Information
- Table 84. GlaxoSmithKline Plc Business Overview
- Table 85. GlaxoSmithKline Plc Purpura Therapy Drugs Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
- Table 86. GlaxoSmithKline Plc Purpura Therapy Drugs Product Portfolio
- Table 87. GlaxoSmithKline Plc Recent Developments
- Table 88. Novartis AG Company Information
- Table 89. Novartis AG Business Overview
- Table 90. Novartis AG Purpura Therapy Drugs Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
- Table 91. Novartis AG Purpura Therapy Drugs Product Portfolio
- Table 92. Novartis AG Recent Developments
- Table 93. Takeda Company Information
- Table 94. Takeda Business Overview
- Table 95. Takeda Purpura Therapy Drugs Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2020-2025)
- Table 96. Takeda Purpura Therapy Drugs Product Portfolio
- Table 97. Takeda Recent Developments
- Table 98. Global Purpura Therapy Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Table 99. Global Purpura Therapy Drugs Sales by Region (2020-2025) & (k pcs)
- Table 100. Global Purpura Therapy Drugs Sales Market Share by Region (2020-2025)
- Table 101. Global Purpura Therapy Drugs Sales by Region (2026-2031) & (k pcs)
- Table 102. Global Purpura Therapy Drugs Sales Market Share by Region (2026-2031)
- Table 103. Global Purpura Therapy Drugs Revenue by Region (2020-2025) & (US$ Million)
- Table 104. Global Purpura Therapy Drugs Revenue Market Share by Region (2020-2025)
- Table 105. Global Purpura Therapy Drugs Revenue by Region (2026-2031) & (US$ Million)
- Table 106. Global Purpura Therapy Drugs Revenue Market Share by Region (2026-2031)
- Table 107. North America Purpura Therapy Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 108. North America Purpura Therapy Drugs Sales by Country (2020-2025) & (k pcs)
- Table 109. North America Purpura Therapy Drugs Sales by Country (2026-2031) & (k pcs)
- Table 110. North America Purpura Therapy Drugs Revenue by Country (2020-2025) & (US$ Million)
- Table 111. North America Purpura Therapy Drugs Revenue by Country (2026-2031) & (US$ Million)
- Table 112. Europe Purpura Therapy Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 113. Europe Purpura Therapy Drugs Sales by Country (2020-2025) & (k pcs)
- Table 114. Europe Purpura Therapy Drugs Sales by Country (2026-2031) & (k pcs)
- Table 115. Europe Purpura Therapy Drugs Revenue by Country (2020-2025) & (US$ Million)
- Table 116. Europe Purpura Therapy Drugs Revenue by Country (2026-2031) & (US$ Million)
- Table 117. Asia Pacific Purpura Therapy Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 118. Asia Pacific Purpura Therapy Drugs Sales by Country (2020-2025) & (k pcs)
- Table 119. Asia Pacific Purpura Therapy Drugs Sales by Country (2026-2031) & (k pcs)
- Table 120. Asia Pacific Purpura Therapy Drugs Revenue by Country (2020-2025) & (US$ Million)
- Table 121. Asia Pacific Purpura Therapy Drugs Revenue by Country (2026-2031) & (US$ Million)
- Table 122. South America Purpura Therapy Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 123. South America Purpura Therapy Drugs Sales by Country (2020-2025) & (k pcs)
- Table 124. South America Purpura Therapy Drugs Sales by Country (2026-2031) & (k pcs)
- Table 125. South America Purpura Therapy Drugs Revenue by Country (2020-2025) & (US$ Million)
- Table 126. South America Purpura Therapy Drugs Revenue by Country (2026-2031) & (US$ Million)
- Table 127. Middle East and Africa Purpura Therapy Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 128. Middle East and Africa Purpura Therapy Drugs Sales by Country (2020-2025) & (k pcs)
- Table 129. Middle East and Africa Purpura Therapy Drugs Sales by Country (2026-2031) & (k pcs)
- Table 130. Middle East and Africa Purpura Therapy Drugs Revenue by Country (2020-2025) & (US$ Million)
- Table 131. Middle East and Africa Purpura Therapy Drugs Revenue by Country (2026-2031) & (US$ Million)
- Table 132. Global Purpura Therapy Drugs Sales by Type (2020-2025) & (k pcs)
- Table 133. Global Purpura Therapy Drugs Sales by Type (2026-2031) & (k pcs)
- Table 134. Global Purpura Therapy Drugs Sales Market Share by Type (2020-2025)
- Table 135. Global Purpura Therapy Drugs Sales Market Share by Type (2026-2031)
- Table 136. Global Purpura Therapy Drugs Revenue by Type (2020-2025) & (US$ Million)
- Table 137. Global Purpura Therapy Drugs Revenue by Type (2026-2031) & (US$ Million)
- Table 138. Global Purpura Therapy Drugs Revenue Market Share by Type (2020-2025)
- Table 139. Global Purpura Therapy Drugs Revenue Market Share by Type (2026-2031)
- Table 140. Global Purpura Therapy Drugs Price by Type (2020-2025) & (US$/pcs)
- Table 141. Global Purpura Therapy Drugs Price by Type (2026-2031) & (US$/pcs)
- Table 142. Global Purpura Therapy Drugs Sales by Application (2020-2025) & (k pcs)
- Table 143. Global Purpura Therapy Drugs Sales by Application (2026-2031) & (k pcs)
- Table 144. Global Purpura Therapy Drugs Sales Market Share by Application (2020-2025)
- Table 145. Global Purpura Therapy Drugs Sales Market Share by Application (2026-2031)
- Table 146. Global Purpura Therapy Drugs Revenue by Application (2020-2025) & (US$ Million)
- Table 147. Global Purpura Therapy Drugs Revenue by Application (2026-2031) & (US$ Million)
- Table 148. Global Purpura Therapy Drugs Revenue Market Share by Application (2020-2025)
- Table 149. Global Purpura Therapy Drugs Revenue Market Share by Application (2026-2031)
- Table 150. Global Purpura Therapy Drugs Price by Application (2020-2025) & (US$/pcs)
- Table 151. Global Purpura Therapy Drugs Price by Application (2026-2031) & (US$/pcs)
- Table 152. Key Raw Materials
- Table 153. Raw Materials Key Suppliers
- Table 154. Purpura Therapy Drugs Distributors List
- Table 155. Purpura Therapy Drugs Customers List
- Table 156. Purpura Therapy Drugs Industry Trends
- Table 157. Purpura Therapy Drugs Industry Drivers
- Table 158. Purpura Therapy Drugs Industry Restraints
- Table 159. Authors List of This Report
- List of Figures
- Figure 1. Research Methodology
- Figure 2. Research Process
- Figure 3. Key Executives Interviewed
- Figure 4. Purpura Therapy Drugs Product Image
- Figure 5. Global Purpura Therapy Drugs Revenue (US$ Million), 2020 VS 2024 VS 2031
- Figure 6. Global Purpura Therapy Drugs Market Size (2020-2031) & (US$ Million)
- Figure 7. Global Purpura Therapy Drugs Sales (2020-2031) & (k pcs)
- Figure 8. Global Purpura Therapy Drugs Average Price (US$/pcs) & (2020-2031)
- Figure 9. Allergic Purpura Product Image
- Figure 10. Thrombocytopenic Purpura Product Image
- Figure 11. Hospital Use Product Image
- Figure 12. Clinic Use Product Image
- Figure 13. Household Product Image
- Figure 14. Others Product Image
- Figure 15. Global Purpura Therapy Drugs Revenue Share by Manufacturers in 2024
- Figure 16. Global Manufacturers of Purpura Therapy Drugs, Manufacturing Sites & Headquarters
- Figure 17. Global Top 5 and 10 Purpura Therapy Drugs Players Market Share by Revenue in 2024
- Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 19. Global Purpura Therapy Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Figure 20. Global Purpura Therapy Drugs Sales by Region in 2024
- Figure 21. Global Purpura Therapy Drugs Revenue by Region in 2024
- Figure 22. North America Purpura Therapy Drugs Market Size by Country in 2024
- Figure 23. North America Purpura Therapy Drugs Sales Market Share by Country (2020-2031)
- Figure 24. North America Purpura Therapy Drugs Revenue Market Share by Country (2020-2031)
- Figure 25. United States Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 26. Canada Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 27. Mexico Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 28. Europe Purpura Therapy Drugs Market Size by Country in 2024
- Figure 29. Europe Purpura Therapy Drugs Sales Market Share by Country (2020-2031)
- Figure 30. Europe Purpura Therapy Drugs Revenue Market Share by Country (2020-2031)
- Figure 31. Germany Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 32. France Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 33. U.K. Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 34. Italy Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 35. Russia Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 36. Spain Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 37. Netherlands Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 38. Switzerland Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 39. Sweden Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 40. Poland Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 41. Asia Pacific Purpura Therapy Drugs Market Size by Country in 2024
- Figure 42. Asia Pacific Purpura Therapy Drugs Sales Market Share by Country (2020-2031)
- Figure 43. Asia Pacific Purpura Therapy Drugs Revenue Market Share by Country (2020-2031)
- Figure 44. China Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 45. Japan Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 46. South Korea Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 47. India Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 48. Australia Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 49. Taiwan Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 50. Southeast Asia Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 51. Southeast Asia Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 52. South America Purpura Therapy Drugs Market Size by Country in 2024
- Figure 53. South America Purpura Therapy Drugs Sales Market Share by Country (2020-2031)
- Figure 54. South America Purpura Therapy Drugs Revenue Market Share by Country (2020-2031)
- Figure 55. Brazil Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 56. Argentina Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 57. Chile Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 58. Middle East and Africa Purpura Therapy Drugs Market Size by Country in 2024
- Figure 59. Middle East and Africa Purpura Therapy Drugs Sales Market Share by Country (2020-2031)
- Figure 60. Middle East and Africa Purpura Therapy Drugs Revenue Market Share by Country (2020-2031)
- Figure 61. Egypt Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 62. South Africa Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 63. Israel Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 64. Türkiye Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 65. GCC Countries Purpura Therapy Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 66. Global Purpura Therapy Drugs Sales Market Share by Type (2020-2031)
- Figure 67. Global Purpura Therapy Drugs Revenue Market Share by Type (2020-2031)
- Figure 68. Global Purpura Therapy Drugs Price (US$/pcs) by Type (2020-2031)
- Figure 69. Global Purpura Therapy Drugs Sales Market Share by Application (2020-2031)
- Figure 70. Global Purpura Therapy Drugs Revenue Market Share by Application (2020-2031)
- Figure 71. Global Purpura Therapy Drugs Price (US$/pcs) by Application (2020-2031)
- Figure 72. Purpura Therapy Drugs Value Chain
- Figure 73. Purpura Therapy Drugs Production Mode & Process
- Figure 74. Direct Comparison with Distribution Share
- Figure 75. Distributors Profiles
- Figure 76. Purpura Therapy Drugs Industry Opportunities and Challenges
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
